Blätt­chen & Part­ner advi­ses BSN manage­ment on sale to SCA

Munich, 20 Decem­ber 2016. Blätt­chen & Part­ner has sup­port­ed the manage­ment team of BSN medi­cal (“BSN”) in the sale by EQT VI Limi­t­ed to Svens­ka Cel­lu­losa Aktie­bo­la­get (“SCA”). The tran­sac­tion values BSN at EUR 2.74 bil­li­on.

BSN medi­cal is a lea­ding glo­bal medi­cal device com­pa­ny in the fields of wound care, vas­cu­lar dise­a­se, lym­pho­lo­gy and non-inva­si­ve ortho­pe­dics. The com­pa­ny was foun­ded in 2001 and curr­ent­ly employs 6000 peo­p­le and gene­ra­ted sales of EUR 861 mil­li­on in 2015.

Blätt­chen & Part­ner advi­sed BSN Manage­ment in the con­text of the tran­sac­tion with Prof. Dr. Alex­an­der Götz.